Genomic profiling of human cervical tumors has revealed these to be among the most enriched for multiple PIK3CA mutations in cis or trans (Saito et al, 2020; Sivakumar et al, 2023). The gene discussed is PIK3CA; the disease is uterine cervix neoplasm.